|
|
On The Cover
Opportunities in Oncology Development
Companies are making steady progress into the research of new therapies to treat cancer, which is the second-leading cause of death in the United States.
By Denise Myshko
Features
A 360-Degree View of E-Patient Connections
Four crucial players need to be in place for successful e-connections: patients, physicians, pharmaceutical companies, and technology providers.
By Robin Robinson
Help Wanted: Pharma Bloggers
Blogging is the latest job function in the marketing tool kit for some pharma companies.
By Robin Robinson
Reducing Regulatory Risk for the Development of Drugs, Biologics, and Devices
Organizations that consistently develop and launch new products efficiently in an environment of increasing regulatory scrutiny can successfully manage regulatory risk.
Contributed by Michael Kuehne, ACSYS Inc.
The New Washington Office
A properly staffed and experienced Washington, D.C., office steeped in the corporate history, culture, and interests can better leverage the specific expertise of outside lobbying, public affairs, public relations, and legal firms.
Contributed by Dennis R. Cryer, M.D., FAHA and Donna R. Cryer, J.D., CryerHealth
|
|
